SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-439875
Filing Date
2012-10-29
Accepted
2012-10-29 17:01:24
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d416526d10q.htm 10-Q 953795
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) d416526dex311.htm EX-31.1 9521
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) d416526dex312.htm EX-31.2 9517
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d416526dex321.htm EX-32.1 3269
  Complete submission text file 0001193125-12-439875.txt   7804114

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20120930.xml EX-101.INS 1484755
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20120930.xsd EX-101.SCH 63589
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20120930_cal.xml EX-101.CAL 89418
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20120930_def.xml EX-101.DEF 348103
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20120930_lab.xml EX-101.LAB 473319
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20120930_pre.xml EX-101.PRE 405553
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 121167318
SIC: 2834 Pharmaceutical Preparations